NP / PA
Clark, Aimee
Clark, Aimee was paid $462K by Medicaid between Aug 2022 and Dec 2024, across 20 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 25% of everything it billed.
33Billing provider infoCLARK, AIMEE
PROVIDENCE, RI 02904
PROVIDENCE, RI 02904
33aNPI1235723263assigned 02/20/2021
33bProvider typeFamily Nurse Practitioner
28Total paid$462K
24GClaims5,667
24DCodes billed20
24AFirst – last monthAug 2022 – Dec 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Rhode Island
Rank by total paid#7 of 266
Median peer was paid$31K
This provider vs. median15×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 1,349 | $116K | |
| 2023 | 2,468 | $195K | |
| 2024incomplete | 1,850 | $151K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 25% | 1,196 | 1,146 | $118K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 22% | 704 | 694 | $102K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 12% | 662 | 647 | $57K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 12% | 394 | 393 | $55K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 7.0% | 767 | 751 | $33K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.6% | 636 | 617 | $17K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.5% | 114 | 111 | $16K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2.6% | 57 | 50 | $12K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.5% | 146 | 145 | $12K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 2.5% | 322 | 321 | $11K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 2.1% | 45 | 44 | $10K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 247 | 243 | $5K |
8 more codes
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 89 | $5K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 12 | $3K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 30 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 29 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 103 | $2K |
| 81002 | <1% | 74 | $431.23 | |
| 87070 | <1% | 21 | $428.41 | |
| 81025 | <1% | 19 | $257.35 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.